MIR1278: A Drug Target / Disease Biomarker (G100302163)

MIR1278: A Drug Target / Disease Biomarker

MIR1278, also known as interleukin-1278, is a protein that is expressed in a variety of tissues throughout the body. It is a key regulator of immune responses and has been shown to play a role in a number of diseases, including cancer, autoimmune disorders, and chronic obstructive pulmonary disease (COPD).

One of the reasons why MIR1278 has such a significant impact on immune responses is its ability to regulate the production of T cells. T cells are a crucial part of the immune system and are responsible for detecting and responding to foreign substances in the body. MIR1278 helps to ensure that T cells are produced in a timely manner and that they are able to recognize and respond to different types of stimuli.

Another function of MIR1278 is its role in the regulation of cell death. cells by activating programmed cell death, also known as apoptosis. This process is important for removing damaged or dysfunctional cells from the body, which is crucial for maintaining tissue homeostasis and preventing the development of diseases.

MIR1278 has also been shown to play a role in the development and progression of certain types of cancer. For example, studies have shown that MIR1278 is overexpressed in a variety of cancer types, including breast, ovarian, and prostate cancer. This suggests that it may be a useful target for cancer therapies that aim to inhibit its activity.

In addition to its role in immune and cancer regulation, MIR1278 has also been shown to be involved in a number of other processes in the body. For example, it has been shown to play a role in the regulation of inflammation, fibrosis, and cellular communication.

Overall, MIR1278 is a protein that has significant implications for a variety of biological processes in the body. Its ability to regulate T cell production, cell death, and inflammation makes it an attractive target for further research and potentially for the development of new therapies.

Protein Name: MicroRNA 1278

The "MIR1278 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about MIR1278 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets

MIR1279 | MIR128-1 | MIR128-2 | MIR1280 | MIR1281 | MIR1282 | MIR1283-1 | MIR1283-2 | MIR1284 | MIR1285-1 | MIR1285-2 | MIR1286 | MIR1287 | MIR1288 | MIR1289-1 | MIR1289-2 | MIR129-1 | MIR129-2 | MIR1290 | MIR1291 | MIR1292 | MIR1293 | MIR1294 | MIR1295A | MIR1295B | MIR1296 | MIR1297 | MIR1298 | MIR1299 | MIR1301 | MIR1302-1 | MIR1302-10 | MIR1302-11 | MIR1302-2 | MIR1302-3 | MIR1302-4 | MIR1302-5 | MIR1302-6 | MIR1302-7 | MIR1302-8 | MIR1302-9 | MIR1303 | MIR1304 | MIR1305 | MIR1306 | MIR1307 | MIR130A | MIR130B | MIR132 | MIR1321 | MIR1322 | MIR1323 | MIR1324 | MIR133A1 | MIR133A1HG | MIR133A2 | MIR133B | MIR134 | MIR1343 | MIR135A1 | MIR135A2 | MIR135B | MIR136 | MIR137 | MIR137HG | MIR138-1 | MIR138-2 | MIR139 | MIR140 | MIR141 | MIR142 | MIR143 | MIR144 | MIR145 | MIR1468 | MIR1469 | MIR146A | MIR146B | MIR1470 | MIR1471 | MIR147A | MIR147B | MIR148A | MIR148B | MIR149 | MIR150 | MIR151A | MIR151B | MIR152 | MIR153-1 | MIR153-2 | MIR1537 | MIR1538 | MIR1539 | MIR154 | MIR155 | MIR155HG | MIR1587 | MIR15A | MIR15B